Q3
GSK hit by European austerity again
November 1, 2012Sales and Marketing Europe, GSK, Q3, austerity
GlaxoSmithKline suffered in the third quarter as sales fell 5% due to generic competition and austerity measures in Europe.Exceptional sales …
Sharp fall for AstraZeneca
October 26, 2012Sales and Marketing AstraZeneca, Brennan, Q3, Soriot
AstraZeneca saw its third quarter revenue and pre-tax profit both fall 15%, to $6.7 billion and $2 billion, respectively. The …
J&J profits down in Q3
October 17, 2012Sales and Marketing J&J, JJ, Johnson & Johnson, Q3, Risperdal
Johnson & Johnson has reported a 6.5% year-on-year sales increase to $17.1 billion in the third quarter of 2012, a …
The changing of the guard – Q3 round up
November 25, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lipitor, Q3, Ranbaxy
PfizerOf all the patent cliffs in pharma, Lipitor’s expiry represents the biggest. Pfizer is now staring over the precipice, with …
Lonza sees continued recovery in third quarter
November 1, 2011Manufacturing and Production, Sales and Marketing Lonza, Q3, manufacturing and production
Revenue growth at contract manufacturing organisation Lonza in the third quarter was once again undermined by the strength of the …
GSK sees strong Q3 after battling headwinds
October 27, 2011Business Services, Sales and Marketing GSK, GSK. Q3, Q3
GlaxoSmithKline has posted a set of healthy figures for the third quarter, underlying its return to growth after a tough …
Patent expiries bite into AstraZeneca revenues
October 29, 2010Sales and Marketing AstraZeneca, Crestor, Q3, Seroquel
Generic competition and a major drop off in pandemic influenza products saw AstraZeneca’s revenue fall for the third quarter. Revenue …
Novartis posts strong Q3 results
October 21, 2010Sales and Marketing 2010 financials, Novartis, Novartis quarterly results, Q3, pharma sales
Novartis has posted double digit growth for the third quarter following a strong showing by a number of recently launched …
Roche revenue depressed by plummeting Tamiflu sales
October 15, 2010Sales and Marketing 2010 financials, Q3, Roche
Roche suffered a 3% drop in group revenue in the third quarter as sales of its Tamiflu plummeted by 90 …
Latest content
